… All of the EGFR mutated patients from that study were included in our analysis and we
report updated clinical data in their response to both gefitinib and erlotinib. The second study …

… Comparison between studies showed that gefitinib and erlotinib produced similar response
… and erlotinib in ISEL and BR.21 studies. Thus, in many countries and regions, erlotinib has …

… Post-study crossover means it is challenging to determine the true OS benefit … study was
that specific combinations of post-study therapy were not documented, eg maintenance erlotinib …

… -free survival, and tumor response rate. Exploratory analyses … be an important predictor of
the erlotinib survival effect. Rash (… in 6% of erlotinib-treated patients and each resulted in study …

… In this study we investigated whether combining erlotinib with cisplatin or gemcitabine in
athymic nude mice bearing NSCLC xenograft models acts synergistically or antagonistically in …

… this study was to compare the efficacy and toxicity of erlotinib… control arms of the erlotinib
and gefitinib studies used in this … of erlotinib studies. This similarity excludes any concern that …

… non-small cell lung cancer (NSCLC). Based on the results of two multicenter phase II studies
[1… Our search yielded a total of 496 potentially relevant studies with gefitinib or erlotinib. The …

… We evaluated data from our lung cancer patients to compare the benefits derived from erlotinib
and … We subsequently analyzed tumor tissue from a subgroup of these patients for a pilot …

… In summary, this study demonstrated that both gefitinib and erlotinib showed effective anti-tumor …
Further study with inclusion of both gefitinib and erlotinib in a properly conducted and …

… -cell lung cancer (NSCLC) with activating EGFR mutations. We aimed to assess the safety
and efficacy of erlotinib … the European Tarceva versus Chemotherapy (EURTAC) study, in …